AMA confronts the rise of nootropics

| 3 Min Read

Responding to the safety concerns generated by a growing personal use of nootropics, physicians at the Annual Meeting of the American Medical Association (AMA) today adopted new policy discouraging the nonmedical use of prescription drugs for cognitive enhancement in healthy individuals.

Nootropics – the so-called smart drugs – include a variety of prescription drugs, supplements, or other substances that claim to improve cognitive functions of healthy individuals, particularly executive function, memory, learning or intelligence.

Full press release available when you sign in

Sign in to the AMA website to get the full version of this press release. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Patient in hospital bed

Nurse practitioners’ care linked to 11% longer stays in the ED

| 4 Min Read
Two healthcare workers in conversation

Mid-career physicians report higher burnout rates

| 6 Min Read
Patient in a wheelchair

Shape your state’s hardship exemptions to Medicaid work requirements

| 7 Min Read
Doctor with reassuring hand on smiling patient

What doctors want patients to know about lupus

| 13 Min Read